Low-dose aspirin for preventing recurrent venous thromboembolism. - Wikidata - awgldk - TriplyDB

Low-dose aspirin for preventing recurrent venous thromboembolism.

Low-dose aspirin for preventing recurrent venous thromboembolism.

http://www.wikidata.org/entity/Q34309660

about

Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis Effective management of venous thromboembolism in the community: non-vitamin K antagonist oral anticoagulants Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis Aspirin for primary prevention of cardiovascular disease Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: an analysis of the implications for perioperative management New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism Assessing the risk of recurrent venous thromboembolism--a practical approach Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation Major bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta-analysis New oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similarities Angiogenic inhibitors for older patients with advanced colorectal cancer: does the age hold the stage?Management of venous thromboembolism: an update Guidance for the treatment of deep vein thrombosis and pulmonary embolism Duration of anticoagulation for venous thromboembolic events Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis Thrombosis: tangled up in NETs.Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study.Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development.Evolving use of new oral anticoagulants for treatment of venous thromboembolism Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation.2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.A review on state-of-the-art data regarding safe early discharge following admission for pulmonary embolism: what do we know?The role of aspirin in the prevention of cardiovascular disease.Thrombo-prophylaxis in acutely ill medical and critically ill patients.Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study An unusual occurrence: a case of venous thromboembolism in pregnancy associated with heterotaxy syndrome Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study.Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk.Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.Clinical Performance of the 1st American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism after Total Knee Arthroplasty in Korean Patients.Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice.Rivaroxaban for the treatment of pulmonary embolism.Elevated prothrombin promotes venous, but not arterial, thrombosis in mice.Use of ASA after warfarin for unprovoked VTE.Development and use of sulodexide in vascular diseases: implications for treatment.

P2860

Q24197581-66F9BDAC-6B73-480E-96F3-9DDE484B7F8B Q26740812-1D365508-636B-4A74-9F99-059B67843E41 Q26746213-F81C5619-E478-4931-9539-75EBF8F499C3 Q26749273-EB6742D7-8571-4B28-899F-43AD0693A6D8 Q26774150-112A5115-A8AD-48BA-BC3E-ABBB1E17A043 Q26781790-8709BCD5-2E28-4C75-B10B-68C69416EDD3 Q26786574-EDC247DE-996D-4E45-A941-08F0DDDAB4B1 Q26796430-B40A397E-7581-4D0D-B42B-FE4BA494B876 Q26825608-8BA0D64F-3B28-4A11-AEFE-4963D7902B4E Q26828750-8ECD50A7-65D5-4B1B-98B9-2D3A73A1E8CB Q27001528-E4B312C0-7086-4B46-9595-0469CCE4737D Q27002538-33807D5F-EC16-4A8C-A3EF-F3374B1E132B Q28071443-E7C8AB2B-E849-436C-9659-DDEDCD2E3C4C Q28078989-E152CF8E-B80F-46D5-9258-9D384F987CFF Q28081375-9D5EF119-5EF9-4B3A-B793-C2BE338C2E14 Q28081717-427AA600-09C3-48F0-9B37-F468132D9944 Q30652065-B9BACCF4-DC44-4B46-9B91-F116BD7F91D4 Q33556910-79C649C7-4131-4E81-935C-326705A2E0E5 Q33724809-7C3CEF2A-0141-4B8B-A5E2-0D12C8D94172 Q33748053-5EBD8B9A-ED19-412A-82FF-E5EF3298EA09 Q34047821-F7559C33-E226-427D-89E1-083E5BF6268C Q34428728-5609DFF6-AF15-4A51-9B85-22F255B26394 Q34436061-773F12B9-716F-468C-AB6A-3AFB150B0A6F Q34536091-CEAAAFCC-5D9D-41BE-BFF1-4044838D16A3 Q34747244-DDCA59B6-0D77-4E58-BA0C-D0C7EA994D7D Q35049359-07519CE2-58BB-4ED1-9692-A9088AE27815 Q35199938-2AE8B431-0C17-4E4A-830B-25E8D31CA2B9 Q35624965-4E2F39EA-EAFF-4A17-A299-8595C4CD712F Q35687307-53424498-C232-4C65-97F1-A057C487CE52 Q35920759-FA8395A6-620B-45E0-B562-F7C7B4B863FE Q36093916-25A1CB26-E332-48DC-9962-9590A0BCC710 Q36192713-70EF9AAB-668D-4825-8A75-FA7FBE65A339 Q36201247-6CEFA855-470F-487B-9B9A-FADF5E58BCB8 Q36276886-3F24E928-809B-4406-A88B-CC27993C8B59 Q36400587-6C1BA657-D3F8-4470-97A6-336982A7FA92 Q36884300-212530D9-8326-46B1-BD16-EEC82118559B Q36997736-958F9694-D975-46B4-B28F-3B68496447B9 Q37189156-F89B0E80-767C-475D-B026-0F14E7354594 Q37230528-4020CA59-64DF-43F6-8605-F5CA175707BB Q37427653-5D9BC289-E952-4983-BDDD-EF65189ECDFA

P2860

Low-dose aspirin for preventing recurrent venous thromboembolism.

http://www.wikidata.org/entity/Q34309660

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Low-dose aspirin for preventing recurrent venous thromboembolism.

@ast

Low-dose aspirin for preventing recurrent venous thromboembolism.

@en

Low-dose aspirin for preventing recurrent venous thromboembolism.

@nl

type

label

Low-dose aspirin for preventing recurrent venous thromboembolism.

@ast

Low-dose aspirin for preventing recurrent venous thromboembolism.

@en

Low-dose aspirin for preventing recurrent venous thromboembolism.

@nl

prefLabel

Low-dose aspirin for preventing recurrent venous thromboembolism.

@ast

Low-dose aspirin for preventing recurrent venous thromboembolism.

@en

Low-dose aspirin for preventing recurrent venous thromboembolism.

@nl

P1433

Q34309660-6E296017-6852-43BF-A11A-5D20FBFAC623

P1476

Q34309660-03016F3D-6974-478F-8DB7-B5BEE02D5B2E

P2093

Q34309660-0607380B-BFA4-488F-8098-B79F73B68B23

Q34309660-30694A40-B7E9-4213-A587-840B2CAE964E

Q34309660-4220E41D-80AA-43A6-9222-D23C35011D59

Q34309660-457C5C4C-D39C-4399-9103-145594AE4923

Q34309660-48DCD2E9-D280-43E1-8DA8-BC0FB6085EE4

Q34309660-68FB8B8A-0A4C-4B28-B1EE-843DF6261BF1

Q34309660-75DC1B10-3400-4E05-90FF-EB625206D8E5

Q34309660-874D9B64-F7D0-4C67-A5D0-1C51B1695BCE

Q34309660-8DFDFB19-1992-437F-A537-B37D71E8C7DA

Q34309660-9304B758-F708-4218-B93F-1EC51B3A9C55

P304

Q34309660-7BE34D85-A3D8-4FEF-A3EF-D780B9957336

P31

Q34309660-C3AF98D1-E0F9-4D93-9BAD-5A3AC2831F36

P356

Q34309660-CBA27AB7-E986-45BC-B5B7-74860AC5DBB5

P407

Q34309660-BB750898-696B-4897-96BD-E92D93671A22

P433

Q34309660-40954969-6F1F-40E6-9E72-89DBDB7F4FE5

P478

Q34309660-2777B8C8-339D-4443-82A2-47A2B4E3699A

P50

Q34309660-F0267EA0-81D9-4207-B8BE-6E1F24B8E9B0

P577

Q34309660-3B6B204B-FE19-4FB7-8DD9-8CEF9B25331C

P698

Q34309660-18BA0AF6-4F3B-4485-8602-91948218FB1F

P921

Q34309660-1946BC01-436E-4EB8-83C0-9C49EA0F2445

P356

P1433

The New England Journal of Medicine

P1476

Low-dose aspirin for preventing recurrent venous thromboembolism.

@en

P2093

ASPIRE Investigators

http://www.w3.org/2001/XMLSchema#string

Adrienne Kirby

http://www.w3.org/2001/XMLSchema#string

Alexander Gallus

http://www.w3.org/2001/XMLSchema#string

Denis Xavier

http://www.w3.org/2001/XMLSchema#string

Harry Gibbs

http://www.w3.org/2001/XMLSchema#string

John Simes

http://www.w3.org/2001/XMLSchema#string

Kristy Mann

http://www.w3.org/2001/XMLSchema#string

Paul Ockelford

http://www.w3.org/2001/XMLSchema#string

Rafael Diaz

http://www.w3.org/2001/XMLSchema#string

Rebecca Mister

http://www.w3.org/2001/XMLSchema#string

P304

1979-1987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1210384

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

367

http://www.w3.org/2001/XMLSchema#string

P50

John W. Eikelboom

P577

2012-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23121403

http://www.w3.org/2001/XMLSchema#string

P921